Literature DB >> 13130392

Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators.

S S Chatterjee1, E L Kondratskaya, O A Krishtal.   

Abstract

The constituents of Ginkgo biloba leaf extract, ginkgolides A, B, C and J are known as effective antagonists of platelet-activating factor (PAF). Here, we will demonstrate that these substances are also effective blockers of glycine-activated chloride channels in the hippocampal neurons of rat. As examined in several other voltage- and ligand-operated channels, this ginkgolide action is selective. The blocking action of all tested ginkgolides is use-dependent--they block open glycine-activated channels. The IC (50) values for saturating blocking action of ginkgolides B and C are 0.273 microM and 0.267 microM, respectively, while ginkgolides A and J are less effective--IC (50) values are 1.97 microM and 2.0 microM. Corresponding dose-response relationships are close to single-site binding isotherms. Another constituent of EGb 761, bilobalide, is a weak inhibitor of NMDA receptor-activated current. Its synthetic analogue, NV-31, demonstrates a weak facilitatory action on Gly-activated conductance. Novel findings have indicated the possibility that the unique modulating activity profiles of the EGb 761 (definition see editorial) constituents examined are due to their effects on the anion homeostasis of central neurons.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13130392     DOI: 10.1055/s-2003-40455

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  7 in total

1.  Role of GABAergic antagonism in the neuroprotective effects of bilobalide.

Authors:  Cornelia Kiewert; Vikas Kumar; Oksana Hildmann; Misty Rueda; Joachim Hartmann; Runa S Naik; Jochen Klein
Journal:  Brain Res       Date:  2006-11-28       Impact factor: 3.252

Review 2.  Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.

Authors:  Christian Ude; Manfred Schubert-Zsilavecz; Mario Wurglics
Journal:  Clin Pharmacokinet       Date:  2013-09       Impact factor: 6.447

3.  Bilobalide induces neuronal differentiation of P19 embryonic carcinoma cells via activating Wnt/β-catenin pathway.

Authors:  Mei Liu; Jingjing Guo; Juan Wang; Luyong Zhang; Tao Pang; Hong Liao
Journal:  Cell Mol Neurobiol       Date:  2014-05-18       Impact factor: 5.046

4.  The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex.

Authors:  T Yoshitake; S Yoshitake; J Kehr
Journal:  Br J Pharmacol       Date:  2010-01-25       Impact factor: 8.739

5.  Ginkgolide B and bilobalide block the pore of the 5-HT₃receptor at a location that overlaps the picrotoxin binding site.

Authors:  Andrew J Thompson; Gavin E Jarvis; Rujee K Duke; Graham A R Johnston; Sarah C R Lummis
Journal:  Neuropharmacology       Date:  2010-11-05       Impact factor: 5.250

6.  Effect of Ginkgo biloba extract on pacemaker channels encoded by HCN gene.

Authors:  Hui Chen; Yongjun Chen; Jing Yang; Pan Wu; Xin Wang; Congxin Huang
Journal:  Herz       Date:  2020-05-20       Impact factor: 1.443

Review 7.  Neuroregulatory role of ginkgolides.

Authors:  Martyna Gachowska; Wojciech Szlasa; Jolanta Saczko; Julita Kulbacka
Journal:  Mol Biol Rep       Date:  2021-07-10       Impact factor: 2.316

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.